{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:34:20Z","timestamp":1787751260634,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.7759\/cureus.95913","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:08:06Z","timestamp":1762020486000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Presumed Insulin-Like Growth Factor 2 (IGF-2)-Mediated Hypoglycemia"],"prefix":"10.7759","author":[{"given":"Kunal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adlyne Reena","family":"Asirvatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Machineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Namratha","family":"Gogineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriraam","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad114.881","article-title":"FRI663: a rare case of IGF-2-induced hypoglycemia associated with metastatic colon cancer","volume":"7","author":"Mohd Mari AA","year":"2023","unstructured":"Mohd Mari AA, Varshney A, Sidhu A, Matos M, Kinaan M. FRI663: a rare case of IGF-2-induced hypoglycemia associated with metastatic colon cancer. J Endocr Soc. 2023, 7:bvad114.881. 10.1210\/jendso\/bvad114.881","journal-title":"J Endocr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007271","article-title":"Hospitalization with hypoglycemia in patients without diabetes mellitus. A retrospective study using a national inpatient database in Japan, 2008-2012","volume":"96","author":"Sako A","year":"2017","unstructured":"Sako A, Yasunaga H, Matsui H, et al.. Hospitalization with hypoglycemia in patients without diabetes mellitus. A retrospective study using a national inpatient database in Japan, 2008-2012. Medicine (Baltimore). 2017, 96:e7271. 10.1097\/MD.0000000000007271","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer PE","year":"2009","unstructured":"Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009, 94:709-28. 10.1210\/jc.2008-1410","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.11.004","article-title":"Non-islet cell tumor hypoglycemia","volume":"37","author":"Scott K","year":"2009","unstructured":"Scott K. Non-islet cell tumor hypoglycemia. J Pain Symptom Manage. 2009, 37:e1-3. 10.1016\/j.jpainsymman.2008.11.004","journal-title":"J Pain Symptom Manage"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00159-9","article-title":"The insulin-like growth factor system and cancer","volume":"195","author":"LeRoith D","year":"2003","unstructured":"LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett. 2003, 195:127-37. 10.1016\/S0304-3835(03)00159-9","journal-title":"Cancer Lett"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00030","article-title":"Novel aspects concerning the functional cross-talk between the insulin\/IGF-I system and estrogen signaling in cancer cells","volume":"6","author":"De Marco P","year":"2015","unstructured":"De Marco P, Cirillo F, Vivacqua A, Malaguarnera R, Belfiore A, Maggiolini M. Novel aspects concerning the functional cross-talk between the insulin\/IGF-I system and estrogen signaling in cancer cells. Front Endocrinol (Lausanne). 2015, 6:30. 10.3389\/fendo.2015.00030","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01175-4","article-title":"IGF-2 mediated hypoglycemia and the paradox of an apparently benign lesion: a case report & review of the literature","volume":"22","author":"Crowley MT","year":"2022","unstructured":"Crowley MT, Lonergan E, O'Callaghan P, Joyce CM, Morita M, Conlon N, O'Halloran DJ. IGF-2 mediated hypoglycemia and the paradox of an apparently benign lesion: a case report & review of the literature. BMC Endocr Disord. 2022, 22:262. 10.1186\/s12902-022-01175-4","journal-title":"BMC Endocr Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore A","year":"2017","unstructured":"Belfiore A, Malaguarnera R, Vella V, et al.. Insulin receptor isoforms in physiology and disease: an updated view. Endocr Rev. 2017, 38:379-431. 10.1210\/er.2017-00073","journal-title":"Endocr Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-006-0606-1","article-title":"The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient","volume":"11","author":"de Boer J","year":"2006","unstructured":"de Boer J, Jager PL, Wiggers T, et al.. The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. Int J Clin Oncol. 2006, 11:478-81. 10.1007\/s10147-006-0606-1","journal-title":"Int J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3915","article-title":"Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: a case report","volume":"11","author":"Huang JS","year":"2016","unstructured":"Huang JS, Chang PH. Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: a case report. Oncol Lett. 2016, 11:898-900. 10.3892\/ol.2015.3915","journal-title":"Oncol Lett"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.01989.x","article-title":"The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia","volume":"60","author":"Teale JD","year":"2004","unstructured":"Teale JD, Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf). 2004, 60:457-60. 10.1111\/j.1365-2265.2004.01989.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.9.7545698","article-title":"Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia","volume":"80","author":"Baxter RC","year":"1995","unstructured":"Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 1995, 80:2700-8. 10.1210\/jcem.80.9.7545698","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.004","article-title":"Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia","volume":"27","author":"Bourcigaux N","year":"2005","unstructured":"Bourcigaux N, Arnault-Ouary G, Christol R, P\u00e9rin L, Charbonnel B, Le Bouc Y. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia. Clin Ther. 2005, 27:246-51. 10.1016\/j.clinthera.2005.02.004","journal-title":"Clin Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa171","article-title":"Pasireotide: a novel treatment for tumor-induced hypoglycemia due to insulinoma and non-islet cell tumor hypoglycemia","volume":"5","author":"Siddiqui M","year":"2021","unstructured":"Siddiqui M, Vora A, Ali S, Abramowitz J, Mirfakhraee S. Pasireotide: a novel treatment for tumor-induced hypoglycemia due to insulinoma and non-islet cell tumor hypoglycemia. J Endocr Soc. 2021, 5:bvaa171. 10.1210\/jendso\/bvaa171","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426403-a-rare-case-of-presumed-insulin-like-growth-factor-2-igf-2-mediated-hypoglycemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T18:08:07Z","timestamp":1762020487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426403-a-rare-case-of-presumed-insulin-like-growth-factor-2-igf-2-mediated-hypoglycemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.95913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}